Inicio | NGcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancer
Publicado clinical_trials NGcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancer has 11 revisions.